The 4 Stocks That Sank the Market

Investing

Published: April 11, 2014 4:01 pm

Last Updated: April 28, 2020 6:19 am

April 11, 2014: Markets opened lower on Friday with the S&P 500 and the Nasdaq Composite breaking into positive territory late in the morning. Unfortunately neither index could hold the gain as investors appear to believe that a major correction may be in the works. At the close of trading today the DJIA was down 0.73%, the S&P 500 was down 0.82%, and the Nasdaq Composite was down 1.26%.

The financial services sector was hit hard today thanks to a weak earnings report from Dow stock JPMorgan Chase & Co. (NYSE: JPM). The big bank traded at $55.47 posting a drop of 3.35% shortly before today’s closing bell. The stock’s 52-week range is $46.05 to $61.48. Share volume was about double the daily average of nearly 20 million shares traded. The bank’s mortgage lending business tanked in the first quarter, down 68% year-over-year.

The Dow’s most heavily weighted stock, Visa Inc. (NYSE: V) traded down 2.37% at $196.73 in a 52-week range of $161.27 to $235.50. The weak showing by JPMorgan has surely spilled over to Visa which will report first-quarter results on April 24th. Volume was about 65% higher than the daily average of around 3.6 million shares traded.

The third-worst performing Dow 30 stock today was The Goldman Sachs Group Inc. (NYSE: GS). The bank reports results next Thursday and today’s showing by Morgan didn’t sit well with investors. The stock traded at $152.96, down 1.97% in a 52-week range of $137.29 to $181.13. Volume was nearly 45% above the daily average of around 3.6 million shares traded.

The big loser on the Nasdaq 100 today was Intuitive Surgical Inc. (NASDAQ: ISRG) which slipped 3.17% and traded at $439.24 in a 52-week range of $351.14 to $541.23. Volume was about less than 10% below the daily average of around 650,000 shares traded. The company cut its earnings estimates Wednesday night and the shares are down about 10% since.

But on the Nasdaq, what one biotech gave away, another put back. Gilead Sciences Inc. (NASDAQ: GILD) traded up 1.23% at $66.28 on Friday in a 52-week range of $46.70 to $84.88. Shares fell 7% yesterday on word of a challenge to Gilead’s cancer drug from Merck & Co. (NYSE: MRK). Trading volume was more than double the daily average of about 15 million shares.

Of the Dow 30 stocks 22 closed lower today and just 8 closed higher.

ALSO READ: Four Stocks to Own as the Market Sells Off

Are You Ahead, or Behind on Retirement? (sponsor)

If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: are you ahead, or behind on your retirement goals?

Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With SmartAsset’s free tool, you can connect with vetted financial advisors in minutes.

Why wait? Click here to get started today!